You need read it again. Stalmer clearly said the partial clinical hold is set for chronic administration. They need new pharmacological evidence for PBT2 as antibiotics as I have told you half a year before. Then they could be entitled to have a discussion with FDA. Hopefully more data will be reported in the coming months.
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-8
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.233K | 885.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 90514720 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20531083 | 18 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 500000 | ||
| Last updated 15.07pm 14/06/2024 ? | |||||
| ATH (ASX) Chart |